ATE362756T1 - Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen - Google Patents

Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen

Info

Publication number
ATE362756T1
ATE362756T1 AT03758040T AT03758040T ATE362756T1 AT E362756 T1 ATE362756 T1 AT E362756T1 AT 03758040 T AT03758040 T AT 03758040T AT 03758040 T AT03758040 T AT 03758040T AT E362756 T1 ATE362756 T1 AT E362756T1
Authority
AT
Austria
Prior art keywords
pain
acid salts
free injection
injection preparations
arylpropionic acid
Prior art date
Application number
AT03758040T
Other languages
English (en)
Inventor
Marco Gentile
Maria Dragani
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Application granted granted Critical
Publication of ATE362756T1 publication Critical patent/ATE362756T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03758040T 2002-10-25 2003-10-22 Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen ATE362756T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02023954 2002-10-25

Publications (1)

Publication Number Publication Date
ATE362756T1 true ATE362756T1 (de) 2007-06-15

Family

ID=32116228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03758040T ATE362756T1 (de) 2002-10-25 2003-10-22 Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen

Country Status (10)

Country Link
US (1) US7442832B2 (de)
EP (1) EP1558234B1 (de)
CN (1) CN1329029C (de)
AT (1) ATE362756T1 (de)
AU (1) AU2003274060A1 (de)
DE (1) DE60313998T2 (de)
ES (1) ES2287519T3 (de)
MX (1) MXPA05004377A (de)
RU (1) RU2340334C2 (de)
WO (1) WO2004037242A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2510196C (en) 2002-12-20 2014-04-01 Generipharm, Inc. Intracutaneous injection
US20070265344A1 (en) * 2006-02-06 2007-11-15 Pharmaceutical Solutions, Inc. Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals
FR2950533B1 (fr) * 2009-09-28 2012-01-13 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
AU2012225268B2 (en) 2011-03-10 2016-10-20 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of peptide drugs
EA027744B1 (ru) 2011-10-31 2017-08-31 Ксерис Фармасьютикалс, Инк. Лекарственные формы для лечения сахарного диабета
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CN102885766B (zh) * 2012-11-05 2014-06-18 西安德天药业股份有限公司 一种右旋酮洛芬注射液及其制备方法
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
WO2016022831A1 (en) 2014-08-06 2016-02-11 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
KR20240036128A (ko) 2017-06-02 2024-03-19 엑스에리스 파머수티클스, 인크. 침전 방지 저분자 약물 제제
EP3670489A1 (de) 2018-12-21 2020-06-24 Dompé farmaceutici S.p.A. Cokristall von ketoprofen, zusammensetzungen damit, verfahren zur herstellung davon und verwendungen davon
SI3996699T1 (sl) 2019-07-09 2023-10-30 Farmalider, S. A. Kombinacija ibuprofena in tramadola za lajšanje bolečine
EP3842408A1 (de) 2019-12-23 2021-06-30 Dompé farmaceutici S.p.A. Co-kristall von ketoprofen und dessen herstellung, pharmazeutische zusammensetzungen damit und verwendungen davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761204B1 (de) * 1995-09-07 1998-04-15 L'oreal Verwendung von Extrakten aus filamentösen, nicht photosynthetischen Bakterien sowie ihre Zusammensetzungen
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
CN1260172A (zh) * 1998-12-18 2000-07-19 国家医药管理局上海医药工业研究院 右旋酮洛芬制剂
US6342530B1 (en) * 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt

Also Published As

Publication number Publication date
AU2003274060A1 (en) 2004-05-13
DE60313998T2 (de) 2008-01-31
RU2005115865A (ru) 2006-01-20
RU2340334C2 (ru) 2008-12-10
ES2287519T3 (es) 2007-12-16
US7442832B2 (en) 2008-10-28
WO2004037242A1 (en) 2004-05-06
CN1720037A (zh) 2006-01-11
US20060058386A1 (en) 2006-03-16
EP1558234B1 (de) 2007-05-23
HK1084336A1 (en) 2006-07-28
DE60313998D1 (de) 2007-07-05
MXPA05004377A (es) 2005-07-26
EP1558234A1 (de) 2005-08-03
CN1329029C (zh) 2007-08-01

Similar Documents

Publication Publication Date Title
ATE362756T1 (de) Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen
EA199700201A1 (ru) Парентеральные фармацевтические композиции, содержащие алкиламмониевые соли 2-арилпропиновых кислот
ATE306917T1 (de) Pharmazeutische zusammensetzung mit 2-(4- isobutylphenyl) propionsäure
HUP9803044A2 (hu) Ibuprofentartalmú készítmény
EA200701913A1 (ru) Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом
DK0584108T3 (da) Farmaceutisk præparat omfattende ibuprofensalt
ES2099022B1 (es) Composiciones farmaceuticas que contienen las sales de acido s(+)-2-(4-isobutilfenil) propionico con aminoacidos basicos.
TR200200252T2 (tr) Şimerik polipeptidler, bunların üretimi için yöntem ve kullanımı
EA200000331A1 (ru) Фармацевтические композиции, содержащие белок плазмы
DE69622157D1 (de) Zusammensetzung zur verhinderung von osteolyse und metastasen
RU95112575A (ru) Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция
CY1115707T1 (el) Στερεα σταθεροποιημενα θεραπευτικα συστηματα ταχειας και/ή τροποποιημενης απελευθερωσης για τη χορηγηση απο του στοματος υγρων δραστικων ουσιων, εκδοχων ή τροφιμων
EA200100168A1 (ru) Схема лечения при введении фенилацетилглутамина, фенилацетилизоглутамина и/или фенилацетата
ATE353009T1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
PL321238A1 (en) Compositions of amino acids and their application in clinical nourishing
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
DE69900756D1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
WO2001087265A3 (de) Pharmazeutische darreichungsform für peptide, verfahren zu deren herstellung und verwendung
ATE401350T1 (de) Dentalzubereitungen enthaltend peptide, die das knochenwachstum fördern
DE60110185D1 (de) Zusammensetzung und Verfahren zur parenteralen Anwendung von Ibuprofen-D,L-, oder L-Lysinat
EP1285660A4 (de) Zinksupplement-zusammensetzungen zur oralen verabreichung
EA200301295A1 (ru) Полипептид, его конъюгат с доксорубицином и фармацевтическая композиция на его основе
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
ES2150421T3 (es) Nuevos conjugados, consistentes en una glicoproteina y una sustancia que se fija a acidos nucleicos.
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties